Ceritinib (trade name Zykadia ) is a prescription-only drug used for the treatment non-small cell lung cancer (NSCLC). It was developed by Novartis and received FDA approval for use in April 2014.
Zykadia Ceritinib 150 mg 150 Capsules sells for roughly $17,200 in the United States.
Ceritinib（Spexib ) sells in India at roughly 25% of the price in the United States.
Natco Pharma Ltd, India's largest pharmaceutical company, launched Noxalk Ceritinib 150mg, a generic drug of Zykadia.
Noxalk Ceritinib 150mg sells for 90 Capsules at only 5% of Zykadia in the United States.
This gives patients more and cheaper choices.
450 mg Ceritinib orally once daily with food，Each box of 90 capsules can be taken for one month.